卫宁健康收盘上涨1.32%，滚动市盈率289.29倍，总市值221.49亿元

Core Viewpoint - The company, Weining Health, has a high rolling price-to-earnings (PE) ratio of 289.29, significantly above the industry average of 120.22, indicating potential overvaluation in the software development sector [1][2]. Group 1: Company Performance - As of July 8, Weining Health's stock closed at 10.01 yuan, with a 1.32% increase [1]. - The company reported a revenue of 345 million yuan for Q1 2025, reflecting a year-on-year decrease of 30.24% [1]. - The net profit for the same period was 5.29 million yuan, down 68.18% year-on-year, with a gross margin of 34.46% [1]. Group 2: Shareholding and Market Position - As of Q1 2025, 21 institutions held shares in Weining Health, including 19 funds, with a total holding of approximately 29.25 million shares valued at 3.16 billion yuan [1]. - The total market capitalization of Weining Health is 22.149 billion yuan [1][2]. Group 3: Industry Comparison - The average PE ratio for the software development industry is 120.22, with a median of 86.10, positioning Weining Health at the 175th rank within the industry [1][2]. - The industry average price-to-book (PB) ratio is 9.05, while the median is 4.00, indicating a higher valuation compared to peers [2].